Open-mkt buys · 90d
—
0 trades · 0 insiders
Open-mkt sales · 90d
—
0 trades · 0 insiders
Net · 90d
$0
Insiders on file
14
Daily buy vs sell · 90 days
No data yet.
Insiders
| Insider | Role | Trades | Bought | Sold | Last trade |
|---|---|---|---|---|---|
| LaChapelle Robin | Chief Operating Officer | 28 | $0 | $0 | 2026-10-30 |
| Parsey Merdad | Director | 3 | $0 | $0 | 2026-06-18 |
| Nolet Chris | Director | 3 | $0 | $0 | 2026-06-18 |
| Hohneker John | Director | 3 | $0 | $0 | 2026-06-18 |
| Peterson Kristine | Director | 3 | $0 | $0 | 2026-06-18 |
| Lutzker Stuart | President of R&D | 2 | $0 | $0 | 2026-02-02 |
| Kastenmayer James Paul | General Counsel | 2 | $0 | $0 | 2026-02-02 |
| Kung Winston | Chief Financial Officer | 2 | $0 | $0 | 2026-02-02 |
| Yao Zhengbin | President and CEO | 2 | $0 | $0 | 2026-02-02 |
| HHLR ADVISORS, LTD. | 10% Owner | 6 | $10.00M | $12.98M | 2025-12-10 |
| OrbiMed Asia GP IV, L.P. | Director, 10% Owner | 10 | $8.00M | $0 | 2024-01-30 |
| GORDON CARL L | Director, 10% Owner | 10 | $8.00M | $0 | 2024-01-30 |
| HEALY JAMES | Director | 3 | $8.00M | $0 | 2024-01-30 |
| Jallal Bahija | Director | 1 | $0 | $0 | 2024-01-25 |
Trade history
| Insider | Role | Code | Trade | Filed | Shares | Price | Value | Owned after | |
|---|---|---|---|---|---|---|---|---|---|
| LaChapelle Robin | Chief Operating Officer | M Exercise deriv | 2026-10-30 | 2026-11-02 | 17,648 | — | $0 | 38,823 | SEC↗ |
| LaChapelle Robin | Chief Operating Officer | M Exercise deriv | 2026-10-30 | 2026-11-02 | 16,265 | — | $0 | 2,600 | SEC↗ |
| LaChapelle Robin | Chief Operating Officer | M Exercise deriv | 2026-10-30 | 2026-11-02 | 1,820 | — | $0 | 0 | SEC↗ |
| LaChapelle Robin | Chief Operating Officer | M Exercise deriv | 2026-10-30 | 2026-11-02 | 4,550 | — | $0 | 1,820 | SEC↗ |
| LaChapelle Robin | Chief Operating Officer | M Exercise deriv | 2026-10-30 | 2026-11-02 | 410 | — | $0 | 0 | SEC↗ |
| LaChapelle Robin | Chief Operating Officer | M Exercise | 2026-10-30 | 2026-11-02 | 17,648 | $6.24 | $110.1K | 176,429 | SEC↗ |
| LaChapelle Robin | Chief Operating Officer | M Exercise | 2026-10-30 | 2026-11-02 | 1,820 | $2.28 | $4.2K | 158,781 | SEC↗ |
| LaChapelle Robin | Chief Operating Officer | M Exercise | 2026-10-30 | 2026-11-02 | 4,550 | $2.28 | $10.4K | 156,961 | SEC↗ |
| LaChapelle Robin | Chief Operating Officer | M Exercise | 2026-10-30 | 2026-11-02 | 410 | $2.28 | $935 | 152,411 | SEC↗ |
| LaChapelle Robin | Chief Operating Officer | M Exercise | 2026-10-30 | 2026-11-02 | 16,265 | $3.65 | $59.4K | 152,001 | SEC↗ |
| Nolet Chris | Director | A Award deriv | 2026-06-18 | 2026-06-22 | 13,562 | — | $0 | 13,562 | SEC↗ |
| Hohneker John | Director | A Award deriv | 2026-06-18 | 2026-06-22 | 13,562 | — | $0 | 13,562 | SEC↗ |
| Peterson Kristine | Director | A Award deriv | 2026-06-18 | 2026-06-22 | 13,562 | — | $0 | 13,562 | SEC↗ |
| Parsey Merdad | Director | A Award deriv | 2026-06-18 | 2026-06-22 | 13,562 | — | $0 | 13,562 | SEC↗ |
| Kastenmayer James Paul | General Counsel | A Award deriv | 2026-02-02 | 2026-02-04 | 130,000 | — | $0 | 130,000 | SEC↗ |
| Yao Zhengbin | President and CEO | A Award deriv | 2026-02-02 | 2026-02-04 | 550,000 | — | $0 | 550,000 | SEC↗ |
| Kung Winston | Chief Financial Officer | A Award deriv | 2026-02-02 | 2026-02-04 | 140,000 | — | $0 | 140,000 | SEC↗ |
| Lutzker Stuart | President of R&D | A Award deriv | 2026-02-02 | 2026-02-04 | 150,000 | — | $0 | 150,000 | SEC↗ |
| LaChapelle Robin | Chief Operating Officer | A Award deriv | 2026-02-02 | 2026-02-04 | 130,000 | — | $0 | 130,000 | SEC↗ |
| HHLR ADVISORS, LTD. | 10% Owner | S Sale | 2025-12-10 | 2026-02-03 | 555,555 | $23.37 | $12.98M | 3,929,117 | SEC↗ |
| LaChapelle Robin | Chief Operating Officer | M Exercise deriv | 2025-07-11 | 2025-07-15 | 2,050 | — | $0 | 410 | SEC↗ |
| LaChapelle Robin | Chief Operating Officer | M Exercise deriv | 2025-07-11 | 2025-07-15 | 6,503 | — | $0 | 6,370 | SEC↗ |
| LaChapelle Robin | Chief Operating Officer | M Exercise deriv | 2025-07-11 | 2025-07-15 | 2,600 | — | $0 | 12,873 | SEC↗ |
| LaChapelle Robin | Chief Operating Officer | M Exercise | 2025-07-11 | 2025-07-15 | 2,600 | $2.28 | $5.9K | 129,233 | SEC↗ |
| LaChapelle Robin | Chief Operating Officer | M Exercise | 2025-07-11 | 2025-07-15 | 6,503 | $2.28 | $14.8K | 135,736 | SEC↗ |
| LaChapelle Robin | Chief Operating Officer | M Exercise | 2025-07-11 | 2025-07-15 | 2,050 | $2.28 | $4.7K | 126,633 | SEC↗ |
| Nolet Chris | Director | A Award deriv | 2025-06-18 | 2025-06-20 | 15,502 | — | $0 | 15,502 | SEC↗ |
| Hohneker John | Director | A Award deriv | 2025-06-18 | 2025-06-20 | 15,502 | — | $0 | 15,502 | SEC↗ |
| Peterson Kristine | Director | A Award deriv | 2025-06-18 | 2025-06-20 | 15,502 | — | $0 | 15,502 | SEC↗ |
| Parsey Merdad | Director | A Award deriv | 2025-06-18 | 2025-06-20 | 15,502 | — | $0 | 15,502 | SEC↗ |
| Parsey Merdad | Director | A Award deriv | 2025-04-28 | 2025-04-29 | 28,346 | — | $0 | 28,346 | SEC↗ |
| Kastenmayer James Paul | General Counsel | A Award deriv | 2025-02-03 | 2025-02-14 | 102,000 | — | $0 | 102,000 | SEC↗ |
| Kung Winston | Chief Financial Officer | A Award deriv | 2025-02-03 | 2025-02-14 | 120,000 | — | $0 | 120,000 | SEC↗ |
| LaChapelle Robin | Chief Operating Officer | A Award deriv | 2025-02-03 | 2025-02-14 | 120,000 | — | $0 | 120,000 | SEC↗ |
| Lutzker Stuart | President of R&D | A Award deriv | 2025-02-03 | 2025-02-14 | 120,000 | — | $0 | 120,000 | SEC↗ |
| Yao Zhengbin | President and CEO | A Award deriv | 2025-02-03 | 2025-02-14 | 380,000 | — | $0 | 380,000 | SEC↗ |
| LaChapelle Robin | Chief Operating Officer | M Exercise deriv | 2024-09-19 | 2024-09-23 | 2,700 | — | $0 | 56,471 | SEC↗ |
| LaChapelle Robin | Chief Operating Officer | M Exercise deriv | 2024-09-19 | 2024-09-23 | 12,364 | — | $0 | 18,865 | SEC↗ |
| LaChapelle Robin | Chief Operating Officer | M Exercise deriv | 2024-09-19 | 2024-09-23 | 7,164 | — | $0 | 15,473 | SEC↗ |
| LaChapelle Robin | Chief Operating Officer | M Exercise deriv | 2024-09-19 | 2024-09-23 | 2,867 | — | $0 | 22,637 | SEC↗ |
| LaChapelle Robin | Chief Operating Officer | M Exercise deriv | 2024-09-19 | 2024-09-23 | 2,471 | — | $0 | 2,460 | SEC↗ |
| LaChapelle Robin | Chief Operating Officer | M Exercise | 2024-09-19 | 2024-09-23 | 2,867 | $2.28 | $6.5K | 102,584 | SEC↗ |
| LaChapelle Robin | Chief Operating Officer | M Exercise | 2024-09-19 | 2024-09-23 | 2,700 | $6.24 | $16.8K | 99,717 | SEC↗ |
| LaChapelle Robin | Chief Operating Officer | M Exercise | 2024-09-19 | 2024-09-23 | 7,164 | $2.28 | $16.3K | 109,748 | SEC↗ |
| LaChapelle Robin | Chief Operating Officer | M Exercise | 2024-09-19 | 2024-09-23 | 12,364 | $3.65 | $45.1K | 124,583 | SEC↗ |
| LaChapelle Robin | Chief Operating Officer | M Exercise | 2024-09-19 | 2024-09-23 | 2,471 | $2.28 | $5.6K | 112,219 | SEC↗ |
| Hohneker John | Director | A Award deriv | 2024-05-16 | 2024-05-20 | 29,550 | — | $0 | 29,550 | SEC↗ |
| Peterson Kristine | Director | A Award deriv | 2024-04-22 | 2024-04-23 | 28,587 | — | $0 | 28,587 | SEC↗ |
| HEALY JAMES | Director | C Conversion deriv | 2024-01-30 | 2024-01-31 | 1,252,308 | — | $0 | 0 | SEC↗ |
| GORDON CARL L | Director, 10% Owner | C Conversion deriv | 2024-01-30 | 2024-01-31 | 821,827 | — | $0 | 0 | SEC↗ |
| GORDON CARL L | Director, 10% Owner | C Conversion deriv | 2024-01-30 | 2024-01-31 | 469,615 | — | $0 | 0 | SEC↗ |
| GORDON CARL L | Director, 10% Owner | C Conversion deriv | 2024-01-30 | 2024-01-31 | 821,827 | — | $0 | 0 | SEC↗ |
| GORDON CARL L | Director, 10% Owner | C Conversion deriv | 2024-01-30 | 2024-01-31 | 469,615 | — | $0 | 0 | SEC↗ |
| OrbiMed Asia GP IV, L.P. | Director, 10% Owner | C Conversion deriv | 2024-01-30 | 2024-01-31 | 469,615 | — | $0 | 0 | SEC↗ |
| OrbiMed Asia GP IV, L.P. | Director, 10% Owner | C Conversion deriv | 2024-01-30 | 2024-01-31 | 469,615 | — | $0 | 0 | SEC↗ |
| OrbiMed Asia GP IV, L.P. | Director, 10% Owner | C Conversion deriv | 2024-01-30 | 2024-01-31 | 821,827 | — | $0 | 0 | SEC↗ |
| OrbiMed Asia GP IV, L.P. | Director, 10% Owner | C Conversion deriv | 2024-01-30 | 2024-01-31 | 821,827 | — | $0 | 0 | SEC↗ |
| HHLR ADVISORS, LTD. | 10% Owner | C Conversion deriv | 2024-01-30 | 2024-02-01 | 4,761,903 | — | $0 | 0 | SEC↗ |
| HHLR ADVISORS, LTD. | 10% Owner | C Conversion deriv | 2024-01-30 | 2024-02-01 | 55,000,000 | — | $0 | 0 | SEC↗ |
| HEALY JAMES | Director | P Buy | 2024-01-30 | 2024-01-31 | 444,444 | $18.00 | $8.00M | 1,696,752 | SEC↗ |
| HEALY JAMES | Director | C Conversion | 2024-01-30 | 2024-01-31 | 1,252,308 | — | $0 | 1,252,308 | SEC↗ |
| GORDON CARL L | Director, 10% Owner | P Buy | 2024-01-30 | 2024-01-31 | 222,222 | $18.00 | $4.00M | 1,513,664 | SEC↗ |
| GORDON CARL L | Director, 10% Owner | C Conversion | 2024-01-30 | 2024-01-31 | 821,827 | — | $0 | 821,827 | SEC↗ |
| GORDON CARL L | Director, 10% Owner | C Conversion | 2024-01-30 | 2024-01-31 | 821,827 | — | $0 | 821,827 | SEC↗ |
| GORDON CARL L | Director, 10% Owner | C Conversion | 2024-01-30 | 2024-01-31 | 469,615 | — | $0 | 1,291,442 | SEC↗ |
| GORDON CARL L | Director, 10% Owner | P Buy | 2024-01-30 | 2024-01-31 | 222,222 | $18.00 | $4.00M | 1,513,664 | SEC↗ |
| GORDON CARL L | Director, 10% Owner | C Conversion | 2024-01-30 | 2024-01-31 | 469,615 | — | $0 | 1,291,442 | SEC↗ |
| OrbiMed Asia GP IV, L.P. | Director, 10% Owner | C Conversion | 2024-01-30 | 2024-01-31 | 821,827 | — | $0 | 821,827 | SEC↗ |
| OrbiMed Asia GP IV, L.P. | Director, 10% Owner | C Conversion | 2024-01-30 | 2024-01-31 | 821,827 | — | $0 | 821,827 | SEC↗ |
| OrbiMed Asia GP IV, L.P. | Director, 10% Owner | C Conversion | 2024-01-30 | 2024-01-31 | 469,615 | — | $0 | 1,291,442 | SEC↗ |
| OrbiMed Asia GP IV, L.P. | Director, 10% Owner | C Conversion | 2024-01-30 | 2024-01-31 | 469,615 | — | $0 | 1,291,442 | SEC↗ |
| OrbiMed Asia GP IV, L.P. | Director, 10% Owner | P Buy | 2024-01-30 | 2024-01-31 | 222,222 | $18.00 | $4.00M | 1,513,664 | SEC↗ |
| OrbiMed Asia GP IV, L.P. | Director, 10% Owner | P Buy | 2024-01-30 | 2024-01-31 | 222,222 | $18.00 | $4.00M | 1,513,664 | SEC↗ |
| HHLR ADVISORS, LTD. | 10% Owner | C Conversion | 2024-01-30 | 2024-02-01 | 3,616,041 | — | $0 | 3,616,041 | SEC↗ |
| HHLR ADVISORS, LTD. | 10% Owner | P Buy | 2024-01-30 | 2024-02-01 | 555,555 | $18.00 | $10.00M | 4,484,672 | SEC↗ |
| HHLR ADVISORS, LTD. | 10% Owner | C Conversion | 2024-01-30 | 2024-02-01 | 313,076 | — | $0 | 3,929,117 | SEC↗ |
| Jallal Bahija | Director | A Award deriv | 2024-01-25 | 2024-01-29 | 17,884 | — | $0 | 17,884 | SEC↗ |
| Nolet Chris | Director | A Award deriv | 2024-01-25 | 2024-01-29 | 17,884 | — | $0 | 17,884 | SEC↗ |